TABLE 1 .
E. coli O104:H4 analyzed in this study
| Isolate namea | Date of isolation | Location of isolation (additional epidemiological information, if available) |
Antibiotic resistance profileb |
Clinical syndrome |
|---|---|---|---|---|
| 55989 (17, 18) | Late 1990s | Bangui, Central African Republic | TET | Diarrhea |
| 01-09591 (12) | 2001 | Germany | Not available | HUS |
| Ec04-8351 (11, 52) | 2004 | Lille, France | NAL | Not available |
| Ec09-7901 (11, 52) | 2009 | Lyon, France | NAL | HUS |
| TY2482 (14) | 2011 | Germany (2011 outbreak) | AMX CAZ CRO STR SSS TMP SXT TET NAL |
HUS |
| Ec11-9941 | 6 Sept 2011 | Angers, France (sporadic) | AMX STR SSS TMP SXT NAL |
HUS |
| Ec11-9990 | 24 Aug 2011 | Besançon, France (sporadic) | AMX TMP NAL | HUS |
| Ec11-9450 | 3 Oct 2011 | France (sporadic; patient became ill in Turkey, returned to France) |
AMX STR SSS TMP SXT TET NAL |
HUS |
| Ec12-0465 | 4 Nov 2011 | Marseille, France (sporadic) | AMX STR SSS TMP SXT TET NAL |
HUS |
| Ec12-0466 | 9 Dec 2011 | Bry-sur-Marne, France (sporadic; recent travel to North Africa) |
AMX STR SSS TMP SXT TET NAL |
HUS |
a
Bolded names refer to isolates sequenced in this study. Numbers in parentheses indicate the bibliographic reference of previously sequenced isolates.
b
Abbreviations are as follows. AMX, amoxicillin; CAZ, ceftazidime; CRO, ceftriaxone; STR, streptomycin; SSS, sulfonamides; TMP, trimethoprim; SXT, sulfamethoxazole; TET, tetracycline; NAL, nalidixic acid.